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A B S T R A C T
To examine effects of varied freezing conditions on the development of spatial heterogeneity in the
frozen protein solution, macroscopic freeze concentration and micro-segregation of bovine serum
albumin (BSA) were investigated in a temperature-controlled 200-ml freeze container. Freezing to 40 C
promoted formation of protein concentration gradients (69–114 mg ml1) in frozen samples taken from
12 different freezer positions, whereby slow freezing in 4 h or longer facilitated the evolution of strong
spatial heterogeneities and caused local concentration increases by 1.15-fold relative to the initial protein
concentration (100 mg ml1). To visualize protein micro-segregation during phase separation, BSA was
conjugated with ﬂuorescein isothiocyanate and confocal laser scanning ﬂuorescence microscopy was
used to localize and size the freeze-concentrated protein regions. Slow freezing resulted in distinctly
fewer and larger protein domains in the frozen bulk than fast freezing. Surface stress on the protein
during freezing would therefore be minimized at low cooling rates; microscopic freeze concentration
would however be highest under these conditions, potentially favoring protein aggregation.
ã 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Proteins are high-value products of biotechnology with a
rapidly growing importance on pharmaceutical markets [4,19,27].
The high costs of their production (e.g. Ref. [16]) makes it necessary
that proteins are stabilized and stored with only minimum
alteration of their biological activity [2,21,26]. Besides freeze
drying [6,7,15], freezing is often used for preservation and storage
of protein solutions [9,22]. Physically, freezing involves partition-
ing of the protein solution into an ice phase and a freeze-
concentrated liquid [1]. Proteins like other solutes are rejected
from the ice [8]. Spatial segregation of the protein is thus induced
[5,25]. The consequent change in microenvironment involves
various stresses on the protein, including exposure to solid ice
surfaces and molecular crowding, which can result in unfolding
and aggregation [5,13,20,24,28]. The freezing process should be
designed to minimize loss of product quality due to critical stresses
incurred. Understanding of how process control variables (e.g. the
cooling rate, degree of supercooling) impact the freezing-induced
phase separation at different scales would be highly important to* Corresponding author at: Institute of Biotechnology and Biochemical Engineer-
ing, Graz University of Technology, Petersgasse 12, A-8010 Graz, Austria.
Tel.: +43 316 873 8400; fax: +43 316 873 8434.
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2215-017X/ã 2015 The Author. Published by Elsevier B.V. This is an open access article unassess consequent effects on protein stability [3,9–11,12,14,22].
Studies at microliter scale have quantiﬁed spatial heterogeneity in
frozen lysozyme solutions prepared by different freezing protocols,
showing a protein freeze concentration by up to 7-fold [5].
Denaturation of lysozyme at the interface region of ice and liquid
was also demonstrated [5]. However, in view of freezing as a unit
operation of industrial biotechnology, investigations of the
freezing-induced phase separation and the resulting protein freeze
concentration must also be performed at larger scale and in
controlled apparatus of deﬁned geometry [9,10,17,22]. Here,
evidence from freezing solutions of bovine serum albumin in a
temperature-controlled 200 ml freeze container [18] is presented.
2. Materials and methods
2.1. Materials
BSA was from Sigma–Aldrich. Fluorescein isothiocyanate (FITC)
and other chemicals were from Roth.
2.2. FITC labeling
2.3 ml of FITC solution (1 mg ml1) in anhydrous DMSO was
added in 20-ml aliquots under gentle stirring to 20 ml of BSA
solution (5 mg ml1, 0.5 M sodium carbonate buffer, pH 9.5). Afterder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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solution was added and incubation continued for 2 h. Unbound
FITC was removed and buffer exchanged to 50 mM potassium
phosphate (pH 7.5) using Vivaspin ultraﬁltration. The molar FITC/
BSA ratio (F/P) was determined with the relationships:
F
P
¼ A495
A280  ð0:35  A495Þ=0:614 C
C ¼ 0:876 ¼ 66;433
389  195
66,433 and 389 are BSA and FITC molecular weight, respectively;
195 is absorption E0.1% of bound FITC at 490 nm, (0.35  A495) is a
correction factor for FITC absorbance at 280 nm [11], and 0.614 is
BSA absorption at 280 nm at 1.0 mg ml1. Absorbances measured
(A) are given with wavelength in subscript. They were recorded on
a Beckman Coulter DU 800 spectrophotometer.
2.3. Freezing, sampling, sample processing and analysis
Native BSA and FITC-labeled BSA were used. About 200 ml of
protein solution (0.1 mg ml1) were frozen in a freeze container
(described in Ref. [18]) Silicone oil (M40.165.10 by Huber,
Germany) was used as thermoﬂuid. The different freezing
protocols applied are described in Section 3. Temperature inside
the freeze container was measured with 8-channel PCE-T 800
Multi-Input Thermometer, with probes at seven positions (A–G)
indicated in Fig. 1. Freezing time was deﬁned as the time between
nucleation and complete solidiﬁcation of the bulk, which can be
identiﬁed as a plateau in the measured temperature proﬁles [18].
When seeding was performed, frozen buffer droplets were
introduced next to the cooled container walls as soon as the bulk
temperature was 2 C.
After freezing and equilibration of bulk temperatures, the ice
block was removed from the container. For native BSA concentra-
tion determination, the removed ice block was cut into pieces (1–
12) as indicated in Fig.1. The samples were thawed, and the soluble
BSA concentration was measured in each of them. Roti-Nanoquant
protein assay was used. The FITC label interfered with protein
determination, thus precluding the same protein analysis when
using the FITC–BSA conjugate.
To perform confocal laser scanning microscopic analysis on
frozen material, samples were drilled from the frozen ice block
using a hollow drill with an inner diameter of 25 mm. From each
run three samples were taken from positions I–III, as shown inFig. 1. Schematic illustration of the freeze container with sampling positions 1–12
and I–III indicated. Thermocouples at positions (A–G) are also shown.Fig. 1. Ice cores were stored in 50-ml Falcon tubes at 70 C until
microscopic examination. Images were obtained with a Leica DMI
6000 inverted microscope in a TCS SP5 system. Excitation was at
488 nm, acquisition from 502 to 603 nm. It should be noted that
images presented later on were chosen to represent the predomi-
nant microscopic appearance of the probed position. However,
between 5 and 8 CLSM images with adequate quality were taken
from each position. In addition, for every sample at least one
acquisition of stacked images in z-direction was performed, each
stack containing approx. 50–100 single images. Every single or
stacked image pictured an area of 620  620 mm. It was ensured
through careful comparison of different sample areas that the
images shown are fully representative for the frozen sample as a
whole. Images were collected as fast as possible before any sample
melting through laser beam exposure could occur.
3. Results
3.1. Macroscopic freeze concentration of BSA
Using a common thermoﬂuid set temperature of 40 C,
solutions of unlabeled BSA were frozen at different freezing rates.
The fastest freezing rate involved immediate switch from room to
set temperature. Relatively slower freezing rates involved linear
temperature ramps from room to set temperature over 4 h and
14 h. Freezing over the 4 h temperature ramp involved an
additional seeding step. No seeding was applied during the 14 h
temperature ramp in order to maximize the effect of supercooling.
The rapid lowering of temperature during fast freezing resulted in
immediate nucleation at the container walls, thus making seeding
unnecessary. Aim of the experiments was to evaluate the inﬂuence
of the freezing protocol on freeze concentration at 12 different
points in the freeze container (see Fig. 1). Results are summarized
in Table 1. Analysis of the protein distribution across the different
sampling positions 1–12 is based on a total protein recovery of 95%
or greater.
Spatial characteristics of BSA freeze concentration were similar
in each experiment where protein concentrations were highest in
the slowly freezing central region of the container around the
longitudinal axis, in particular at positions 6 and 7. In container
side regions that froze fastest (positions 1, 4, 9 and 12), by contrast,
BSA concentrations were lowest. The freeze concentration can be
characterized by the maximum and minimum protein concen-
trations observed across the container. Slowing down the freezing
rate resulted in increased protein concentrations in the maximally
freeze-concentrated regions of the container. The minimum
protein concentration was lowest for the seeded 4-h freezing
run, and also the ratio between maximum and minimum protein
concentration was highest under these conditions. Maximum/
minimum protein concentration ratios of between 1.4 and
1.7 indicate macroscopic freeze concentration to have been
substantial under all freeze conditions used.
Considering the protein distribution in frozen bulk (Table 1) and
assuming comparable cryoconcentration patterns of labeled and
unlabeled BSA, positions I–III were chosen in regions with low,
intermediate and high protein concentrations to obtain samples
for microscopic imaging by CLSM analysis.
3.2. Visualization of the distribution of freeze-concentrated FITC–BSA
conjugate
The FITC-labeled BSA preparation used had a F/P ratio of 3.4. For
CLSM imaging experiments, fast freezing (freezing time = 53 min)
and 4-h seeded freezing (freezing time = 87 min) were performed
as in Table 1. In addition, a 4-h freezing run was done without
seeding (freezing time = 73 min) to induce supercooling. Seeding
Table 1
Spatially resolved protein distribution in BSA solutions frozen at different freezing rates (fast, 4 h, 14 h) to thermoﬂuid temperature of 40 C. Sampling positions 1–12 refer to
Fig. 1. N is the number of replicate freezing runs. Seeding was performed in the 4-h freezing run. Results are given in percent concentration (C) where 100% equals the initial
solution concentration of 0.1 mg l1. Mean values  standard deviations are shown. Range = Cmax Cmin; Ratio = Cmax/Cmin.
Freeze rate 1 2 3 4 5 6 7 8 9 10 11 12 Range Ratio
Fast
N = 5
86  5 91  8 92  5 86  7 100  13 102  10 104  8 95  9 77  6 84  4 86  7 80  3 31  9 1.4  0.1
4 h
N = 3
70  7 82  6 83  6 78  3 88  6 110  6 109  4 93  5 69  2 77  6 78  8 72  4 45  4 1.7  0.1
14 h
N = 3
80  2 87  3 91  2 85  2 104  5 113  2 114  5 110  2 75  5 78  6 81  5 78  4 40  1 1.5  0.04
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was decreased linearly to 40 C within 12 h (freezing time = 4 h
22 min). Note that the set temperature decreases were comparable
but not identical to the freezing experiments described in Table 1.
Representative images from CLSM analysis of ice core samples
are shown in Fig. 2 where images are arranged by position and
freezing time. Note: in the non-seeded 4-h freezing experiment
(freezing time = 73 min), supercooling was achieved in the whole
bulk whereby just before spontaneous nucleation, temperatures of
4.6 C and 1.0 C were recorded in peripheral (thermocouples B,
C, F, E in Fig. 1) and central regions of the freeze container
(thermocouples A, G, D in Fig. 1), respectively.
In most of the sample images, irregular distributions of labeled
protein were found. Protein was accumulated in localized and
contained regions, circular or elongated in shape and approxi-
mately 10–100 mm in diameter or length. Ice growth direction
could be identiﬁed from the parallel alignment of the concentrated
protein regions at freezing times of 87 min and 4 h 22 min (position
I + II) as well as after 53 min (position I). In the central position III,
protein inclusions appeared unordered, irrespective of the freezing
time.
The distance between the freeze-concentrated regions varied
with the duration of freezing. In positions I–II, distances increased
from a few 10 mm at short freezing time to several 100 mm at high
freezing time. The size of protein domains was biggest at theFig. 2. CLSM images from frozen FITC–BSA core samples taken at positions I–III. The ap
nucleation and complete solidiﬁcation of the bulk. It is not the full time of the freezing ex
were obtained with a Leica DMI 6000 inverted microscope in a TCS SP5 system. Excita
Samples were placed in a plastic dish with a glass slide bottom while dry ice was used for 
laser beam exposure could occur. Multiple images were collected from each position. It 
shown were fully representative for the frozen sample as a whole. (For interpretation of th
this article.)slowest freezing time (4 h 22 min), in any of the three sampling
positions.
4. Discussion
Freezing induced a substantial amount of macroscopic spatial
heterogeneity in BSA solutions (Table 1). Maximum BSA concen-
tration in freeze-concentrated regions increased on increase in the
freezing time. Ratio between maximum and minimum protein
concentration also changed on variation of the freezing rate.
Explanations for the macroscopic observations were found
through analysis of microscopic effects of the freezing, as follows.
Of the sampling positions selected for CLSM analysis, position
III was located in the freeze container’s very last point to freeze and
as expected, it was the one to show the highest protein
concentration. The remaining positions (I, II) represented faster
freezing points of the container, and they exhibited decreased
protein concentration. Fig. 2 shows that freeze-concentrated
protein regions were formed in larger number and bigger size at
sampling position III, as compared to positions I and II, under
conditions of slow freezing (87 min, 4 h 22 min). The effect was
weakened (73 min) or even absent (53 min) at faster freezing rates.
Fig. 2 also shows that slower freezing times (87 min, 4 h 22 min)
resulted in fewer and larger freeze-concentrated regions and also
in wider protein-free regions, except for position III (see below).plied freezing times are indicated. Note: freezing time measures the time between
periment. In the highlighted experiment (pink), no seeding was performed. Images
tion was at 488 nm, acquisition from 502 to 603 nm. Magniﬁcation was 630-fold.
cooling. Images were collected as fast as possible before any sample melting through
was ensured through careful comparison of different sample areas that the images
e references to color in this ﬁgure legend, the reader is referred to the web version of
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freeze-concentrated regions, as revealed on comparing the 53 min
and 4 h 22 min freezing runs at the position I and position II. The
effect of seeding is made evident by comparing the 73 min and
87 min freezing runs. In the non-seeded 73 min run, freeze-
concentrated protein regions were much smaller and distributed in
a way more irregular fashion than in the seeded 87 min run.
Microscopic protein distribution at position I is relevant in
particular: almost instant solidiﬁcation of the whole sampling
position was noticed after spontaneous nucleation whereas in the
seeded experiment, the freezing occurred much slower in this
region. The comparably regular (linear) appearance of freeze-
concentrated protein regions in the seeded experiment is therefore
noted, at position I but also at position II. Linear alignment of the
protein domains could be caused by dendritic ice growth, which is
often found in bulk-scale freezing [23]. One expects dendritic
growth to be pronounced under conditions where solidiﬁcation
occurs relatively slow, as in the seeded experiment with its low
degree of supercooling.
There are practical ramiﬁcations of the evidence presented.
Formation of a relatively large number of freeze-concentrated
protein domains under conditions of fast freezing implies
pronounced exposure of proteins to ice crystal surfaces. High
cooling rates could therefore be unfavorable for freezing of surface-
sensitive proteins. At slow freezing rates, fewer and larger protein
domains are present. It is quite likely that the protein concentra-
tion will be higher in the large as compared to the small domains
and therefore, slow freezing may create problems with proteins
having low solubility limits and tend to native-like aggregation.
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